ALXN
AssetMark Inc’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-53,936
| Closed | -$9.91M | – | 1563 |
|
|
2021
Q2 | $9.91M | Buy |
+53,936
| New | +$9.91M | 0.05% | 225 |
|
|
2021
Q1 | – | Sell |
-73
| Closed | -$11K | – | 1581 |
|
|
2020
Q4 | $11K | Sell |
73
-5
| -6% | -$753 | ﹤0.01% | 917 |
|
|
2020
Q3 | $9K | Buy |
78
+1
| +1% | +$115 | ﹤0.01% | 928 |
|
|
2020
Q2 | $9K | Sell |
77
-1
| -1% | -$117 | ﹤0.01% | 880 |
|
|
2020
Q1 | $7K | Sell |
78
-25,862
| -100% | -$2.32M | ﹤0.01% | 1052 |
|
|
2019
Q4 | $2.81M | Buy |
25,940
+25,723
| +11,854% | +$2.78M | 0.02% | 298 |
|
|
2019
Q3 | $21K | Sell |
217
-152
| -41% | -$14.7K | ﹤0.01% | 879 |
|
|
2019
Q2 | $48K | Sell |
369
-502
| -58% | -$65.3K | ﹤0.01% | 707 |
|
|
2019
Q1 | $118K | Sell |
871
-106
| -11% | -$14.4K | ﹤0.01% | 543 |
|
|
2018
Q4 | $95K | Buy |
977
+469
| +92% | +$45.6K | ﹤0.01% | 571 |
|
|
2018
Q3 | $71K | Buy |
508
+1
| +0.2% | +$140 | ﹤0.01% | 668 |
|
|
2018
Q2 | $63K | Buy |
507
+16
| +3% | +$1.99K | ﹤0.01% | 673 |
|
|
2018
Q1 | $55K | Sell |
491
-7
| -1% | -$784 | ﹤0.01% | 705 |
|
|
2017
Q4 | $60K | Buy |
498
+234
| +89% | +$28.2K | ﹤0.01% | 736 |
|
|
2017
Q3 | $37K | Sell |
264
-5
| -2% | -$701 | ﹤0.01% | 772 |
|
|
2017
Q2 | $33K | Buy |
269
+13
| +5% | +$1.6K | ﹤0.01% | 785 |
|
|
2017
Q1 | $31K | Buy |
256
+14
| +6% | +$1.7K | ﹤0.01% | 766 |
|
|
2016
Q4 | $30K | Sell |
242
-99
| -29% | -$12.3K | ﹤0.01% | 764 |
|
|
2016
Q3 | $42K | Buy |
341
+107
| +46% | +$13.2K | ﹤0.01% | 665 |
|
|
2016
Q2 | $27K | Buy |
234
+77
| +49% | +$8.89K | ﹤0.01% | 776 |
|
|
2016
Q1 | $22K | Buy |
157
+56
| +55% | +$7.85K | ﹤0.01% | 746 |
|
|
2015
Q4 | $19K | Buy |
101
+93
| +1,163% | +$17.5K | ﹤0.01% | 809 |
|
|
2015
Q3 | $1K | Buy |
+8
| New | +$1K | ﹤0.01% | 696 |
|